berobenatide
Sponsor Pfizer INC · listed as PFE
berobenatide is a drug asset sponsored by Pfizer INC, listed as PFE. CSA tracks 2 forward catalysts for it — the nearest is a readout expected Feb 16, 2028 (day precision, medium confidence), tied to trial NCT07845500. That trial is in Phase 3 and currently not yet recruiting, studying Obesity. It appears across 5 tracked trials in the CSA sample.
Next catalyst
Trial & sponsor
All tracked catalysts for berobenatide
| Date | Event | Confidence | Trial |
|---|---|---|---|
| 2028-02-16 | READOUT | medium | NCT07845500 |
| 2028-03-14 | READOUT | medium | NCT07792954 |
Trials for berobenatide in the CSA sample
| Trial | Phase | Status | Primary completion | Role | Lead sponsor | Condition(s) |
|---|---|---|---|---|---|---|
| NCT07845500 catalyst | Phase 3 | Not yet recruiting | 2028-02-16 | Experimental | Pfizer | Obesity; Overweight and/or Obesity; Overweight; Treatment Of Obesity |
| NCT07792954 catalyst | Phase 3 | Not yet recruiting | 2028-03-14 | Experimental | Pfizer | Obesity; Overweight |
| NCT07823608 | Phase 3 | Recruiting | 2028-04-30 | Experimental | Pfizer | Apnea; Sleep Disorders; Overweight and/or Obesity |
| NCT07794774 | Phase 3 | Not yet recruiting | 2029-02-21 | Experimental | Pfizer | Obesity |
| NCT07794761 | Phase 3 | Not yet recruiting | 2029-03-14 | Experimental | Pfizer | Obesity |
Each trial links to its ClinicalTrials.gov record; primary completion dates are as registered there.
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This page is one record from the free CSA sample. The full snapshot covers active, industry-sponsored Phase 3 trials in cardiometabolic, oncology and immunology. Every forward catalyst carries its date, confidence grade and source link, and is linked to its sponsor's ticker when the sponsor is a listed company.
Get the full dataset — $499 → More PFE catalysts